Benjamin Graham Detailed Fundamental Analysis

According to Validea's guru fundamental report, Intuitive Surgical (ISRG) receives a 71% rating based on Benjamin Graham's value investing strategy, which favors companies with low price-to-book and price-to-earnings ratios, low debt, and solid long-term earnings growth; ISRG passes Graham's criteria for sales, current ratio, long-term debt in relation to net current assets, and long-term EPS growth, but fails the P/E ratio and price/book ratio tests.

Analysis

Intuitive Surgical Inc. (ISRG) has been evaluated by Validea using Benjamin Graham's value investing model, resulting in a score of 71%. This rating indicates a moderate alignment with the strategy's criteria, falling short of the 80% threshold that typically signals significant interest and the 90% mark for strong interest. The analysis reveals that ISRG, a large-cap growth stock within the Medical Equipment & Supplies industry, successfully meets Graham's criteria for sales, current ratio, minimal long-term debt relative to net current assets, and consistent long-term EPS growth. These factors point towards robust operational health and a sound financial structure. However, the company fails on two critical valuation metrics central to Graham's deep value philosophy: the Price-to-Earnings (P/E) ratio and the Price-to-Book (P/B) ratio. This discrepancy highlights that while ISRG demonstrates strong underlying fundamentals, its current market valuation is considered high by traditional Graham-based value investing standards.

Key Decisions for Investors

• Given ISRG's failure on P/E and Price/Book ratio tests, investors strictly adhering to Benjamin Graham's deep value principles may find the stock currently overvalued, despite its positive performance on debt and long-term EPS growth criteria.
• Investors should weigh ISRG's strong fundamental aspects, such as its solid sales, current ratio, and long-term earnings growth, against its current premium valuation, potentially monitoring for a more attractive entry point if valuation multiples contract or if further analysis justifies the premium based on its growth trajectory.
• Considering ISRG is classified as a large-cap growth stock, the high valuation metrics might be less of a deterrent for growth-focused investors, but value-oriented investors should exercise caution or seek a wider margin of safety.